186 Results for "

fibroblast growth factor receptor

" in MedChemExpress (MCE) Product Catalog:
Products (186)

186 Results for "fibroblast growth factor receptor" in MCE Product Catalog:

20
20 Publications Verification
Cat. No.: HY-N0060
CAS No.: 1135-24-6
Synonyms: Coniferic acid
Ferulic acid is a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor with IC50s of 3.78 and 12.5 μM for FGFR1 and FGFR2, respectively.
loading...
    loading...
20
20 Publications Verification
Cat. No.: HY-N0060A
CAS No.: 24276-84-4
Synonyms: Coniferic acid sodium
Ferulic acid sodium is a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor with IC50s of 3.78 and 12.5 μM for FGFR1 and FGFR2, respectively.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-12823
CAS No.: 1538604-68-0
Purity:  99.97%
Target:  

FGFR

Research Areas:  

Cancer

BLU9931 is a potent, highly selective, and irreversible fibroblast growth factor receptor 4 (FGFR4) inhibitor with an IC50 of 3 nM and a Kd of 6 nM. BLU9931 has significant antitumor activity .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-100019
CAS No.: 1443530-05-9
Purity:  99.86%
Synonyms: BAY1163877
Target:  

FGFR

Research Areas:  

Cancer

Rogaratinib (BAY1163877) is a potent and selective fibroblast growth factor receptor (FGFR) inhibitor. Rogaratinib inhibits FGFRs with IC50s of 11.2 nM (FGFR1), <1 nM (FGFR2), 18.5 nM (FGFR3), 127 nM (VEGFR3/FLT4), 201 nM (FGFR4), respectively .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-100492
CAS No.: 1707289-21-1
Purity:  99.79%
Synonyms: BLU-554
Target:  

FGFR

Research Areas:  

Cancer

Fisogatinib (BLU-554) is a potent, highly selective and orally active fibroblast growth factor receptor 4 (FGFR4) inhibitor with an IC50 of 5 nM. Fisogatinib has significant anti-tumor activity in models of hepatocellular carcinoma (HCC) that are dependent on FGFR4 signalling .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-17601
CAS No.: 1612888-66-0
Synonyms: RPT835
Target:  

FGFR Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

Alofanib (RPT835) is a potent and selective allosteric inhibitor of fibroblast growth factor receptor 2 (FGFR2). Anticancer and antiangiogenic activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114311
CAS No.: 2308497-58-5
Purity:  98.26%
Research Areas:  

Cancer

FGFR1/DDR2 inhibitor 1 is an orally active inhibitor of fibroblast growth factor receptor 1 (FGFR1) and discoindin domain receptor 2 (DDR2), with IC50 values of 31.1 nM and 3.2 nM, respectively. Antitumor activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P990859

Research Areas:  

Cancer

Anti-CD44 Antibody (Hermes-1) is a kind of rat IgG2a κ chimeric antibody, targeting to human CD44. Anti-CD44 Antibody (Hermes-1) blocks the binding of hyaluronan to CD44. Anti-CD44 Antibody (Hermes-1) restores (Platelet-derived Growth Factor-BB)-induced β-receptor activation and motility in fibroblasts. Anti-CD44 Antibody (Hermes-1) causes partial loss of the anti-aging effect of hyaluronic .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0060R
CAS No.: 1135-24-6
Synonyms: Coniferic acid (Standard)
Ferulic acid (Standard) is the analytical standard of Ferulic acid. This product is intended for research and analytical applications. Ferulic acid is a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor with IC50s of 3.78 and 12.5 μM for FGFR1 and FGFR2, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70817
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FGFR3; Mutant fibroblast growth factor receptor 3; Prev. ACH; fibroblast growth factor receptor 3-S; JTK4; fibroblast growth factor receptor; CD333; receptor Protein-Tyrosine Kinase; CEK2; Hydroxyaryl-Protein Kinase; FGFR-3; Tyrosine Kinase JTK4; Fibrobla
Species:  
Human
Source:  
HEK293
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80399
Synonyms: CD333, JTK4, FGFR3, fibroblast growth factor receptor 3, FGFR-3

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P

Reactivity:  

Human, Mouse

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-132817
CAS No.: 2211082-53-8
Purity:  98.52%
Synonyms: ICP-192
Target:  

FGFR

Research Areas:  

Cancer

Gunagratinib (ICP-192) is a low toxicity and orally active pan-FGFR (fibroblast growth factor receptors) inhibitor that potently and selectively inhibits FGFR activities irreversibly by covalent binding. Gunagratinib can be used for the research of cancer . Gunagratinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120006A
CAS No.: 1408311-94-3
Purity:  99.42%
Target:  

ERK

Research Areas:  

Cardiovascular Disease

(rel)-AR234960 is a selective and competitive agonist of the G protein-coupled receptor MAS. (rel)-AR234960 binds to the MAS receptor to activate the downstream ERK1/2 signaling pathway, inducing the expression of connective tissue growth factor (CTGF) and its downstream collagen subtype genes (such as COL1A1, COL3A1). (rel)-AR234960 promotes collagen synthesis in cardiac fibroblasts through the MAS-ERK1/2-CTGF pathway and aggravates extracellular matrix remodeling. (rel)-AR234960's in vitro effect can be blocked by the MAS inverse agonist AR244555 and MEK1 inhibitor. (rel)-AR234960 regulates the expression of cardiac fibrosis-related genes and can be used in the study of heart failure .
loading...
    loading...
Cat. No.: HY-P3503
CAS No.: 1480724-61-5
Synonyms: BMN 111
Target:  

FGFR

Research Areas:  

Others

Vosoritide (BMN 111) is a modified recombinant CNP (C-type natriuretic peptide) analogue, binds to NPR-B (natriuretic peptide receptor type B) and reduces the activity of FGFR3 (fibroblast growth factor receptor 3). Vosoritide can be used in achondroplasia and dwarfism research .
loading...
    loading...
Cat. No.: HY-P99010
CAS No.: 1952272-74-0
Synonyms: AMG-552; FPA-144

Target:  

FGFR

Research Areas:  

Cancer

Bemarituzumab is a humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has antitumor activity against gastric and breast cancer .
loading...
    loading...
Cat. No.: HY-P3281
CAS No.: 499993-62-3
Target:  

FGFR

Research Areas:  

Neurological Disease

FGL peptide is a fibroblast growth factor receptor (FGFR) modulator and blood-brain barrier-penetrant. FGL peptide activates NCAM-FGFR and FGFR1 signaling pathways. FGL peptide alters expression of apoptosis, signal transduction and metabolism regulator genes in traumatic brain injury contexts. FGL peptide can be used for the research of traumatic brain injury .
loading...
    loading...
Cat. No.: HY-131908
CAS No.: 1627826-19-0
Purity:  99.85%
Target:  

FGFR

Research Areas:  

Cancer

CPL304110 is a potent, orally active and selective inhibitor of fibroblast growth factor receptors FGFR (1-3), with IC50 values of 0.75 nM, 0.5 nM, and 3.05 nM for FGFR (1-3), respectively .
loading...
    loading...
Cat. No.: HY-118203
CAS No.: 186610-89-9
Purity:  99.14%
Research Areas:  

Cancer

SU4984 is a protein tyrosine kinase inhibitor, with an IC50 of 10-20 μM for fibroblast growth factor receptor 1 (FGFR1). SU4984 is also inhibits platelet-derived growth factor receptor, and insulin receptor. SU4984 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-P99823
CAS No.: 2226238-09-9
Synonyms: TA-46; sFGFR3

Target:  

FGFR

Research Areas:  

Others

Recifercept (TA-46) is a soluble, recombinant fibroblast growth factor receptor 3 (FGFR3) molecule. Recifercept can be used as a decoy/ligand trap to decrease the amount of fibroblast growth factors that can bind to mutant FGFR3 receptors. Recifercept can be used for the research of achondroplasia .
loading...
    loading...
Cat. No.: HY-170869
Target:  

PROTACs FGFR

Research Areas:  

Cancer

PROTAC FGFR1 degrader-1 is a PROTAC degrader targeting fibroblast growth factor receptor 1 (FGFR1), with a DC50 of 39.78 nM and an IC50 of 26.81 nM in KG1a cells. PROTAC FGFR1 degrader-1 selectively degrades FGFR1 via the ubiquitin-proteasome system, showing concentration- and time-dependent degradation in cancer cells. PROTAC FGFR1 degrader-1 can be used in studies related to leukemia and breast cancer .
loading...
    loading...